| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10354-010-0748-7 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10354-010-0748-7 |
| P698 | PubMed publication ID | 20229156 |
| P2093 | author name string | Guntram Schernthaner | |
| P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
| Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Epidemic obesity and type 2 diabetes in Asia | Q28273485 | ||
| GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients | Q28276621 | ||
| Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk) | Q28345602 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes | Q46531371 | ||
| Effect of a multifactorial intervention on mortality in type 2 diabetes | Q46767642 | ||
| Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis | Q46810855 | ||
| The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. | Q46835037 | ||
| Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart | Q46835041 | ||
| Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects | Q46847408 | ||
| Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. | Q51612089 | ||
| Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. | Q51631787 | ||
| Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm | Q57245341 | ||
| Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials | Q59624463 | ||
| Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients | Q67963458 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf | Q77782556 | ||
| Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus | Q78216138 | ||
| Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04) | Q79750507 | ||
| Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials | Q81897757 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| Intensive insulin therapy in critically ill patients | Q29618795 | ||
| Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
| A randomized trial of therapies for type 2 diabetes and coronary artery disease | Q33827504 | ||
| Intensive insulin therapy in the medical ICU. | Q34490623 | ||
| The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study | Q34623719 | ||
| Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials | Q34686089 | ||
| Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials | Q34781949 | ||
| Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials | Q34982751 | ||
| Intensive glucose control and macrovascular outcomes in type 2 diabetes. | Q34995674 | ||
| Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial | Q37105140 | ||
| Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. | Q37460057 | ||
| Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. | Q37461889 | ||
| Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study | Q37461920 | ||
| Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors | Q37505281 | ||
| Systematic review: glucose control and cardiovascular disease in type 2 diabetes | Q37557021 | ||
| National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study | Q39213508 | ||
| Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial. | Q40025571 | ||
| Insulin Receptor Binding to Monocytes, Insulin Secretion, and Glucose Tolerance Following Metformin Treatment: Results of a Double-Blind Cross-Over Study in Type II Diabetics | Q42455201 | ||
| Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study | Q43222752 | ||
| Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction | Q43233459 | ||
| Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report. | Q43711367 | ||
| Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction | Q44128296 | ||
| Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes | Q44295713 | ||
| Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? | Q44333469 | ||
| Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring | Q44418824 | ||
| Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia | Q44453016 | ||
| Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity | Q44642265 | ||
| Cardiovascular mortality and morbidity in type-2 diabetes mellitus | Q44864586 | ||
| Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes | Q45155012 | ||
| Blood glucose and risk of cardiovascular disease in the Asia Pacific region | Q45161558 | ||
| Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial | Q45173621 | ||
| Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes. | Q45942114 | ||
| [24-hours monitoring of ECG and glucose level for detection of relations between glycemia and QT interval duration in patients with type 1 diabetes] | Q45974960 | ||
| Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. | Q46019125 | ||
| Intensive versus conventional glucose control in critically ill patients | Q46076336 | ||
| Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited | Q46274929 | ||
| A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial | Q46401187 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | glucose | Q37525 |
| cardiovascular disease | Q389735 | ||
| glycobiology | Q899224 | ||
| P304 | page(s) | 8-19 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Wiener Medizinische Wochenschrift | Q2568998 |
| P1476 | title | Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. | |
| P478 | volume | 160 |
| Q28282265 | A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes |
| Q36611527 | Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events |
| Q28082405 | Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review |
| Q35139678 | Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease - a randomized controlled trial |
| Q37810292 | Diabetes area participation analysis: a review of companies and targets described in the 2008 - 2010 patent literature |
| Q35543946 | Diabetes screening: a pending issue in hypertense/obese patients. |
| Q34173849 | Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline |
| Q33640419 | Diabetic maculopathy. Diagnosis and treatment |
| Q35783956 | Durability of glycemic control using U-500 insulin |
| Q37887378 | Epigenetic mechanisms. |
| Q36820255 | Glucose-lowering therapy in type 2 diabetes. New hope after the EMPA-REG outcome trial |
| Q48341477 | Glucose-targeted therapy for subjects with type 2 diabetes mellitus: primum non nocere |
| Q27024469 | Glycemic control and cardiovascular disease: what's a doctor to do? |
| Q90752699 | Greater macrovascular and microvascular morbidity from type 2 diabetes in Northern compared with Southern China: a cross-sectional study |
| Q38257168 | Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications |
| Q36783714 | Hypoglycemia and cardiovascular risks |
| Q35990856 | Hypoglycemia, diabetes, and cardiovascular disease |
| Q41166013 | Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years |
| Q36108287 | Inpatient treatment of type 2 diabetes |
| Q41945946 | Insulin as an early treatment for type 2 diabetes: ORIGIN or end of an old question? |
| Q35044151 | Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes. |
| Q35532277 | Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes. |
| Q37973129 | Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes |
| Q46460686 | Poor glycaemic control and arrhythmias |
| Q26849625 | Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart |
| Q39427404 | Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis |
| Q45895376 | Utility of a post-hospitalization stroke prevention program managed by nurses |
| Q37307286 | Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery |
| Q37834474 | Vasculotoxic effects of insulin and its role in atherosclerosis: what is the evidence? |
| Q85524170 | [Current treatment of type 2 diabetes] |
Search more.